1 research outputs found
Additional file 1: Document S1. of Peginterferon beta-1a improves MRI measures and increases the proportion of patients with no evidence of disease activity in relapsing-remitting multiple sclerosis: 2-year results from the ADVANCE randomized controlled trial
MRI acquisition parameters and analysis. (DOCX 27kb